Systematically Treating the Extra Sweet Pediatric Patient, Without Inadvertently Giving Them a Big Head

Roger L Layell1, Kory A Lane2

  • 1Atrium Health MedCenter Air, Charlotte, NC.

Air Medical Journal
|June 25, 2023
PubMed

Insights

Treating pediatric diabetic ketoacidosis (DKA) requires careful management to prevent cerebral edema and electrolyte imbalances. Rapid correction of blood glucose in children with DKA can worsen these serious complications.

Area of Science:

  • Pediatric Endocrinology
  • Critical Care Medicine
  • Emergency Medicine

Background:

  • Diabetic ketoacidosis (DKA) is a serious complication in pediatric patients with diabetes mellitus.
  • Managing DKA in children, especially during transport, presents unique challenges.
  • Cerebral edema is a significant and often subtle complication of DKA in pediatric populations.

Purpose of the Study:

  • To highlight the complexities of treating pediatric DKA during transport.
  • To emphasize the risks associated with aggressive blood glucose correction.
  • To underscore the potential for rapid and severe complications in pediatric DKA.

Main Methods:

  • This study reviews current literature and clinical guidelines on DKA management in pediatric patients.
  • It focuses on the specific challenges encountered during inter-facility or pre-hospital transport.
  • Analysis includes common pitfalls and best practices for monitoring and treatment.

Main Results:

  • Subtle signs of cerebral edema can be easily missed in pediatric DKA patients.
  • Overly rapid correction of hyperglycemia can precipitate cerebral edema and electrolyte disturbances.
  • Pediatric DKA patients are susceptible to acute and rapidly progressing serious complications.

Conclusions:

  • Careful and controlled management of blood glucose is crucial in pediatric DKA.
  • Vigilant monitoring for subtle signs of cerebral edema is essential during transport.
  • Prompt and appropriate interventions are necessary to mitigate severe outcomes in pediatric DKA.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
319
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
214
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
306
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
605